A pill filled with poo dubbed a crapsule to boost gut health and prevent serious infections is starting a major trial of 300 people in 16 centres across the UK.
Poo Transplant Trial Offers Hope for Liver Disease Patients miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
Marina Wainstein and colleagues examine acute kidney injury (AKI) incidence, severity, and outcomes among patients with COVID-19 using both a traditional and extended definition of AKI.
Marina Wainstein and colleagues examine acute kidney injury (AKI) incidence, severity, and outcomes among patients with COVID-19 using both a traditional and extended definition of AKI.
E-Mail
IMAGE: People with severe COVID-19 manifestations may be left with more of the protective memory T cells needed to fight reinfection. view more
Credit: La Jolla Institute for Immunology
LA JOLLA, CA A big question on people s minds these days: how long does immunity to SARS-CoV-2 last following infection?
Now a research team from La Jolla Institute for Immunology (LJI), The University of Liverpool and the University of Southampton has uncovered an interesting clue. Their new study suggests that people with severe COVID-19 cases may be left with more of the protective memory T cells needed to fight reinfection. The data from this study suggest people with severe COVID-19 cases may have stronger long-term immunity, says study co-leader LJI Professor Pandurangan Vijayanand, M.D., Ph.D.